We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App




Fully Automated FIT Analyzer Designed for Labs with High Fecal Testing Volumes

By LabMedica International staff writers
Posted on 16 Jun 2022

Colorectal Cancer (CRC) is one of the most dangerous and lethal cancers. More...

It represents the second leading cause of cancer related death in the western world with almost two million of new cases/year and 0.9 million deaths. If early diagnosed, CRC is curable in most of the cases, therefore most countries organize national or regional screenings to identify the cancers in their early stage, making the cure more efficient and thus considerably decreasing mortality. Those screening programs are testing millions of people every year and this creates new challenges in the practical organization of the laboratories. Now, a new high throughput analyzer for fecal immunochemical testing can meet the need for throughput, automation and accuracy in the most demanding situations.

Sentinel Diagnostics’ (Milan, Italy) new SENTiFIT 800 analyzer is a fully automated and high throughput system for fecal immunochemical test. The high-end system dedicated to fecal testing is able to process up to 550 tests per hour and one million tests every year with total automation and full traceability. It enables a reduction in hands-on time, better management of resources and decrease in manual errors. The system is fed by a dedicated sample loader (Rack Handler RH-150) that provides a steady flow of up to 250 samples to the analyzer unit.

The CE-marked SENTiFIT 800 Analyzer is compatible with the company’s FOB Gold line, the complete solution for the identification of occult blood in feces, and with its CALiaGold line of reagents for the quantification of fecal Calprotectin, the first-choice test to identify the presence of inflammation in the bowel.

"For almost 20 years, Sentinel Diagnostics has supported the fight against colorectal cancer with high quality FOB Gold test and analyzers," said Marco Buonaguidi, Head of Sales and Marketing at Sentinel Diagnostics. "The SENTiFIT 800 has been developed specifically for FIT screening centers and represents a step further in the direction to strengthen our commitment in the field of gastrointestinal diseases diagnosis."

Related Links:
Sentinel Diagnostics 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.